Vaccine efficacy of NVX-CoV2373 against SARS-CoV-2 infection in adolescents in the USA: an ancillary study to a phase 3, observer-blinded, randomised, placebo-controlled trial.
Deming ME, Brown ER, McArthur MA, Schrag SJ, Arvay M, Humphrys M, Ravel J, Adelglass J, Essink B, Musante DB, Maguire R, Gorman R, Formentini E, Mason R, Robb ML, Neuzil KM, Rapaka RR, Wolff P, Kotloff KL; SNIFF study team.
Deming ME, et al. Among authors: brown er.
Lancet Microbe. 2025 Jan 27:100984. doi: 10.1016/j.lanmic.2024.100984. Online ahead of print.
Lancet Microbe. 2025.
PMID: 39884302
Free article.